Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: Systematic literature review and evidence from studies with miglustat

Orphanet Journal of Rare Diseases

Volumn 7, Issue 1, 2012, Pages

  Walterfang, Mark ^a   Chien, Yin Hsiu ^b   Imrie, Jackie ^c   Rushton, Derren ^d   Schubiger, Danielle ^a   Patterson, Marc C ^e  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d Actelion Pharmaceuticals Pty Ltd   (Australia)

^e MAYO CLINIC   (United States)

Author keywords

Aspiration; Dysphagia; Miglustat.; Mortality; Niemann Pick disease type C; Pneumonia; Swallowing

Indexed keywords

MIGLUSTAT;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASPIRATION; ASPIRATION PNEUMONIA; BRONCHOPNEUMONIA; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; EVIDENCE BASED MEDICINE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; INCIDENCE; LIFESPAN; LONG TERM CARE; MORTALITY; MULTIPLE SCLEROSIS; NIEMANN PICK DISEASE; OLIVOPONTOCEREBELLAR ATROPHY; PARKINSON DISEASE; PREVALENCE; PROGRESSIVE SUPRANUCLEAR PALSY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; SWALLOWING; SYSTEMATIC REVIEW; WILSON DISEASE;

1-DEOXYNOJIRIMYCIN; ANIMALS; DEGLUTITION DISORDERS; HUMANS; NIEMANN-PICK DISEASE, TYPE C;

EID: 84867030083     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-7-76     Document Type: Article

References (142)

1. Niemann-Pick disease type C. Vanier MT, Orphanet J Rare Dis 2010 5 16 10.1186/1750-1172-5-16 20525256
2. Prevalence of lysosomal storage disorders. Meikle PJ, Hopwood JJ, Clague AE, Carey WF, JAMA 1999 281 249 254 10.1001/jama.281.3.249 9918480 (Pubitemid 29058114)
3. Identification of HE1 as the second gene of Niemann-Pick C disease. Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P, Science 2000 290 2298 2301 10.1126/science.290.5500.2298 11125141 (Pubitemid 32041569)
4. Complementation studies in Niemann-Pick disease type C indicate the existence of a second group. Steinberg SJ, Ward CP, Fensom AH, J Med Genet 1994 31 317 320 10.1136/jmg.31.4.317 8071958 (Pubitemid 24127532)
5. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, et al. Science 1997 277 228 231 10.1126/science.277.5323.228 9211849 (Pubitemid 27446076)
6. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease. Lloyd-Evans E, Platt FM, Traffic 2010 11 419 428 10.1111/j.1600-0854.2010.01032.x 20059748
7. The neuropsychiatry of Niemann-Pick type C disease in adulthood. Walterfang M, Fietz M, Fahey M, Sullivan D, Leane P, Lubman DI, Velakoulis D, J Neuropsychiatry Clin Neurosci 2006 18 158 170 10.1176/appi.neuropsych.18.2.158 16720792
8. The adult form of Niemann-Pick disease type C. Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, Sedel F, Brain 2007 130 120 133 17003072 (Pubitemid 46026228)
9. Niemann-Pick disease type C in adults. Imrie J, Vijayaraghaven S, Whitehouse C, Harris S, Heptinstall L, Church H, Cooper A, Besley GT, Wraith JE, J Inherit Metab Dis 2002 25 491 500 10.1023/A:1021259403196 12555942 (Pubitemid 36104384)
10. Natural history of Niemann-Pick disease type C in a multicentre observational retrospective cohort study. Wraith JE, Guffon N, Rohrbach M, Hwu WL, Korenke GC, Bembi B, Luzy C, Giorgino R, Sedel F, Mol Genet Metab 2009 98 250 254 10.1016/j.ymgme.2009.06.009 19616462
11. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series. Pineda M, Perez-Poyato MS, O'Callaghan M, Vilaseca MA, Pocovi M, Domingo R, Portal LR, Perez AV, Temudo T, Gaspar A, et al. Mol Genet Metab 2010 99 358 366 10.1016/j.ymgme.2009.11.007 20056559
12. Niemann-Pick C disease in Spain: clinical spectrum and development of a disability scale. Iturriaga C, Pineda M, Fernandez-Valero EM, Vanier MT, Coll MJ, J Neurol Sci 2006 249 1 6 10.1016/j.jns.2006.05.054 16814322 (Pubitemid 44767636)
13. The natural history of Niemann-Pick disease type C in the UK. Imrie J, Dasgupta S, Besley GT, Harris C, Heptinstall L, Knight S, Vanier MT, Fensom AH, Ward C, Jacklin E, et al. J Inherit Metab Dis 2007 30 51 59 10.1007/s10545-006- 0384-7 17160617 (Pubitemid 46140226)
14. The National Niemann-Pick C1 disease database: report of clinical features and health problems. Garver WS, Francis GA, Jelinek D, Shepherd G, Flynn J, Castro G, Walsh Vockley C, Coppock DL, Pettit KM, Heidenreich RA, Meaney FJ, Am J Med Genet A 2007 143 1204 1211 (Pubitemid 46870076)
15. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, Pineda M, Sedel F, Topcu M, Vanier MT, et al. Mol Genet Metab 2009 98 152 165 10.1016/j.ymgme.2009.06.008 19647672
16. Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Yanjanin NM, Velez JI, Gropman A, King K, Bianconi SE, Conley SK, Brewer CC, Solomon B, Pavan WJ, Arcos-Burgos M, et al. Am J Med Genet B Neuropsychiatr Genet 2010 153B 132 140 19415691
17. Role of videofluoroscopy in evaluation of neurologic dysphagia. Rugiu MG, Acta otorhinolaryngologica Italica: organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 2007 27 306 316
18. The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat. Fecarotta S, Amitrano M, Romano A, Della Casa R, Bruschini D, Astarita L, Parenti G, Andria G, Am J Med Genet A 2011 155A 540 547 21344635
19. Nova Scotia Niemann-Pick disease (type D): clinical study of 20 cases. Jan MM, Camfield PR, J Child Neurol 1998 13 75 78 10.1177/088307389801300206 9512307 (Pubitemid 28155114)
20. Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. Kelly DA, Portmann B, Mowat AP, Sherlock S, Lake BD, J Pediatr 1993 123 242 247 10.1016/S0022-3476(05)81695-6 7688422 (Pubitemid 23221104)
21. Aspiration pneumonitis and aspiration pneumonia. Marik PE, N Engl J Med 2001 344 665 671 10.1056/NEJM200103013440908 11228282 (Pubitemid 32183583)
22. Aspiration pneumonia. Pathophysiological aspects, prevention and management. A review. Petroianni A, Ceccarelli D, Conti V, Terzano C, Panminerva Med 2006 48 231 239 17215795
23. Miglustat (Zavesca) Summary of Product Characteristics http://eudrapharm.eu/eudrapharm/showDocument?documentId=299255761182430949
24. N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. Platt FM, Neises GR, Dwek RA, Butters TD, J Biol Chem 1994 269 8362 8365 8132559
25. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE, Lancet Neurol 2007 6 765 772 10.1016/S1474-4422(07)70194-1 17689147 (Pubitemid 47238662)
26. Long-term miglustat therapy in children with Niemann-Pick disease type C. Patterson MC, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, Giorgino R, Wraith JE, J Child Neurol 2010 25 300 305 10.1177/0883073809344222 19822772
27. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Wraith JE, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, Giorgino R, Patterson MC, Mol Genet Metab 2010 99 351 357 10.1016/j.ymgme.2009.12.006 20045366
28. Type C Niemann-Pick disease: report of a Chinese case. Lyu RK, Ko YM, Hung IJ, Lu CS, J Formos Med Assoc 1993 92 829 831 7904866
29. Treatment of Niemann-Pick disease type C in two children with miglustat: initial responses and maintenance of effects over 1 year. Chien YH, Lee NC, Tsai LK, Huang AC, Peng SF, Chen SJ, Hwu WL, J Inherit Metab Dis 2007 30 826 10.1007/s10545-007-0630-y 17603755
30. Treatment of a child diagnosed with Niemann-Pick disease type C with miglustat: A case report in Brazil. Santos ML, Raskin S, Telles DS, Lohr A Jr, Liberalesso PB, Vieira SC, Cordeiro ML, J Inherit Metab Dis 2008 31 Suppl 2 357 S361 18937049
31. 24 month-treatment with miglustat of three patients with Niemann-Pick disease type C: follow up using brain spectroscopy. Galanaud D, Tourbah A, Lehericy S, Leveque N, Heron B, de Villemeur Billette T, Guffon N, Feillet F, Baumann N, Vanier MT, Sedel F, Mol Genet Metab 2009 96 55 58 10.1016/j.ymgme.2008.10.002 19013089
32. Dysphagia treatment post stroke: a systematic review of randomised controlled trials. Foley N, Teasell R, Salter K, Kruger E, Martino R, Age Ageing 2008 37 258 264 10.1093/ageing/afn064 18456790 (Pubitemid 351639144)
33. The effect of compliance on clinical outcomes for patients with dysphagia on videofluoroscopy. Low J, Wyles C, Wilkinson T, Sainsbury R, Dysphagia 2001 16 123 127 10.1007/s004550011002 11305222 (Pubitemid 32240644)
34. Dysphagia in neurologic patients in the intensive care unit. Langmore SE, Semin Neurol 1996 16 329 340 10.1055/s-2008-1040991 9112312 (Pubitemid 27172693)
35. Aspiration syndromes: aspiration pneumonia and pneumonitis. Marik PE, Hosp Pract (Minneap) 2010 38 35 42 10.3810/hp.2010.02.276
36. Aspiration in patients with acute stroke. Daniels SK, Brailey K, Priestly DH, Herrington LR, Weisberg LA, Foundas AL, Arch Phys Med Rehabil 1998 79 14 19 10.1016/S0003-9993(98)90200-3 9440410 (Pubitemid 28098915)
37. Niemann-Pick disease type C2 presenting as fatal pulmonary alveolar lipoproteinosis: morphological findings in lung and nervous tissue. Bjurulf B, Spetalen S, Erichsen A, Vanier MT, Strom EH, Stromme P, Medical science monitor: international medical journal of experimental and clinical research 2008 14 S71 CS75
38. [Niemann-Pick disease type B: An enzymatically confirmed case with unexpected retinal involvement (author's transl)]. Harzer K, Ruprecht KW, Seuffer-Schulze D, Jans U, Albrecht von Graefe's archive for clinical and experimental ophthalmology 1978 206 79 88 10.1007/BF00414616 (Pubitemid 8301669)
39. An autopsy case of Niemann-Pick disease. Kawai K, Tsuchiyama H, Tabata K, Acta Pathol Jpn 1973 23 837 846 4801712
40. Adult Niemann-Pick disease masquerading as sea blue histiocyte syndrome: report of a case confirmed by lipid analysis and enzyme assays. Landas S, Foucar K, Sando GN, Ellefson R, Hamilton HE, Am J Hematol 1985 20 391 400 10.1002/ajh.2830200411 4073013 (Pubitemid 16222306)
41. Trends in mortality from Alzheimer's disease, Parkinson's disease and dementia, England and Wales, 1979-2004. Griffiths C, Rooney C, Health statistics quarterly / Office for National Statistics 2006 6 14
42. A retrospective survey of treatment and mortality in aspiration pneumonia. Hickling KG, Howard R, Intensive Care Med 1988 14 617 622 3053842
43. Use of tube feeding to prevent aspiration pneumonia. Finucane TE, Bynum JPW, Lancet 1996 348 1421 1424 10.1016/S0140-6736(96)03369-7 8937283 (Pubitemid 26395239)
44. Dysphagia in Huntington's disease: a review. Heemskerk AW, Roos RA, Dysphagia 2011 26 62 66 10.1007/s00455-010-9302-4 20838817
45. Silent aspiration: what do we know? Ramsey D, Smithard D, Kalra L, Dysphagia 2005 20 218 225 10.1007/s00455-005-0018-9 16362510 (Pubitemid 41813286)
46. Neurodegeneration in Niemann-Pick Type C disease and Huntington's disease: impact of defects in membrane trafficking. Schweitzer JK, Krivda JP, D'Souza-Schorey C, Curr Drug Targets 2009 10 653 665 10.2174/138945009788680437 19601769
47. Altered apolipoprotein E glycosylation is associated with Abeta(42) accumulation in an animal model of Niemann-Pick Type C disease. Chua CC, Lim ML, Wong BS, J Neurochem 2010 112 1619 1626 10.1111/j.1471-4159.2010.06586.x 20070866
48. Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: Bridging Niemann-Pick disease type C and Alzheimer's disease. Koh V, Cheung NS, Cellular Signaling 2006 18 1844 1853 10.1016/j.cellsig.2006. 04.006 (Pubitemid 44485995)
49. Cause of death in patients with Huntington's disease and in unaffected first degree relatives. Sorenson ST, Fenger K, J Med Genet 1992 29 911 914 10.1136/jmg.29.12.911 1479606 (Pubitemid 23035219)
50. Cause of death in patients with dementia disorders. Brunnstrom HR, Englund EM, Eur J Neurol 2009 16 488 492 10.1111/j.1468-1331.2008.02503.x 19170740
51. Racial disparities in the development of dysphagia after stroke: analysis of the California (MIRCal) and New York (SPARCS) inpatient databases. Gonzalez-Fernandez M, Kuhlemeier KV, Palmer JB, Arch Phys Med Rehabil 2008 89 1358 1365 10.1016/j.apmr.2008.02.016 18586139 (Pubitemid 351884991)
52. Disorders of swallowing: palliative care. Langmore SE, Grillone G, Elackattu A, Walsh M, Otolaryngol Clin North Am 2009 42 87 105 ix 10.1016/j.otc.2008.09.005 19134493
53. Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. Atsuta N, Watanabe H, Ito M, Tanaka F, Tamakoshi A, Nakano I, Aoki M, Tsuji S, Yuasa T, Takano H, et al. J Neurol Sci 2009 276 163 169 10.1016/j.jns.2008.09.024 18962725
54. The prevention of aspiration pneumonia by early nasogastric tube feeding in acute stroke patients with dysphagia. Ahn SH, Kim DU, Kim HW, Int J Stroke 2010 5 225
55. National Institutes of Health stroke scale assists in predicting the need for percutaneous endoscopic gastrostomy tube placement in acute ischemic stroke. Alshekhlee A, Ranawat N, Syed TU, Conway D, Ahmad SA, Zaidat OO, Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association 2010 19 347 352 10.1016/j.jstrokecerebrovasdis.2009.07.014
56. Consequence of dysphagia in the hospitalized patient: impact on prognosis and hospital resources. Altman KW, Yu GP, Schaefer SD, Arch Otolaryngol Head Neck Surg 2010 136 784 789 10.1001/archoto.2010.129 20713754
57. Laryngopharyngeal sensory testing with modified barium swallow as predictors of aspiration pneumonia after stroke. Aviv JE, Sacco RL, Mohr JP, Thompson JL, Levin B, Sunshine S, Thomson J, Close LG, Laryngoscope 1997 107 1254 1260 10.1097/00005537-199709000-00018 9292613 (Pubitemid 27382523)
58. Functional outcome in brain stem stroke patients after rehabilitation. Chua KSG, Kong KH, Arch Phys Med Rehabil 1996 77 194 197 10.1016/S0003-9993(96) 90167-7 8607746 (Pubitemid 26050689)
59. Long-term outcome of percutaneous endoscopic gastrostomy feeding in patients with dysphagic stroke. James A, Kapur K, Hawthorne AB, Age Ageing 1998 27 671 676 10.1093/ageing/27.6.671 10408659 (Pubitemid 28537614)
60. Dysphagia in patients with brainstem stroke: Incidence and outcome. Meng N-H, Wang T-G, Lien I-N, Am J Phys Med Rehabil 2000 79 170 175 10.1097/00002060-200003000-00010 10744192 (Pubitemid 30204800)
61. Dysphagia screening, assessment and outcomes in stroke patients: Phase 1 of an evidence-based practice project. Perry L, McLaren SM, Journal of Clinical Excellence 2000 1 201 208 (Pubitemid 30179242)
62. Formal swallowing evaluation and therapy after traumatic brain injury improves dysphagia outcomes. Schurr MJ, Ebner KA, Maser AL, Sperling KB, Helgerson RB, Harms B, J Trauma 1999 46 817 821 discussion 821-823 10.1097/00005373-199905000-00009 10338398 (Pubitemid 29228119)
63. Acute multifocal posterior placoid pigment epitheliopathy (AMPPPE) mimicking migraine with aura. Spencer BR Jr, Kunimoto DY, Patel DR, Dodick DW, Cephalalgia: an international journal of headache 2009 29 694 698 10.1111/j.1468-2982.2008.01797.x
64. The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson's disease. Sung HY, Kim JS, Lee KS, Kim YI, Song IU, Chung SW, Yang DW, Cho YK, Park JM, Lee IS, et al. Mov Disord 2010 25 2361 2368 10.1002/mds.23290 20669313
65. Complications of cerebrovascular accident in two tertiary care hospitals of Peshawar, Pakistan. Ali M, Khan Y, Khan H, Iranian Red Crescent Medical Journal 2008 10 261 266
66. Status epilepticus: Clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients. Amare A, Zenebe G, Hammack J, Epilepsia 2008 49 600 607 10.1111/j.1528-1167.2008.01556.x 18325017 (Pubitemid 351661067)
67. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR, Eur J Neurol 2004 11 49 53 10.1046/j.1468-1331.2003.00749. x 14692888 (Pubitemid 38174922)
68. Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease. Fernandez HH, Lapane KL, Medical science monitor: international medical journal of experimental and clinical research 2002 8 R241 246
69. Frequency of complications of stroke. Marwat MA, Hussain M, Khan N, J Med Sci 2010 18 19 21
70. Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study. Pineda M, Wraith JE, Mengel E, Sedel F, Hwu WL, Rohrbach M, Bembi B, Walterfang M, Korenke GC, Marquardt T, et al. Mol Genet Metab 2009 98 243 249 10.1016/j.ymgme.2009.07.003 19656703
71. Videofluoroscopy and swallowing studies for neurologic disease: a primer. Gates J, Hartnell GG, Gramigna GD, Radiographics: a review publication of the Radiological Society of North America, Inc 2006 26 22 10.1148/rg.e22
72. Quantifying swallowing function after stroke: A functional dysphagia scale based on videofluoroscopic studies. Han TR, Paik NJ, Park JW, Arch Phys Med Rehabil 2001 82 677 682 10.1053/apmr.2001.21939 11346847 (Pubitemid 32423586)
73. Efficacy of miglustat on the neurological involvement in Italian patients with Niemann-pick disease type C. Fecarotta S, Astarita L, Bruschini D, Pisani L, Romano A, Del Giudice E, Mansi G, Amitrano M, Dolezalova H, Della Casa R, et al. Mol Genet Metab 2009 98 70
74. Miglustat (Zavesca) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme. Hollak CE, Hughes D, van Schaik IN, Schwierin B, Bembi B, Pharmacoepidemiol Drug Saf 2009 18 770 777 10.1002/pds.1779 19507165
75. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Cox T, Lachmann R, Hollak C, Aerts J, van Weely S, Hrebicek M, Platt F, Butters T, Dwek R, Moyses C, et al. Lancet 2000 355 1481 1485 10.1016/S0140-6736(00)02161-9 10801168 (Pubitemid 30237353)
76. Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease. Elstein D, Hollak C, Aerts JM, van Weely S, Maas M, Cox TM, Lachmann RH, Hrebicek M, Platt FM, Butters TD, et al. J Inherit Metab Dis 2004 27 757 766 15505381 (Pubitemid 39433603)
77. Low-dose N-butyldeoxynojirimycin (OGT 918) for type I Gaucher disease. Heitner R, Elstein D, Aerts J, Weely S, Zimran A, Blood Cells Mol Dis 2002 28 127 133 10.1006/bcmd.2002.0497 12064906 (Pubitemid 34743745)
78. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment. Pastores GM, Barnett NL, Kolodny EH, Clin Ther 2005 27 1215 1227 10.1016/j.clinthera.2005.08. 004 16199246 (Pubitemid 41393915)
79. Gastrointestinal disturbances and their management in miglustat-treated patients. Belmatoug N, Burlina A, Giraldo P, Hendriksz CJ, Kuter DJ, Mengel E, Pastores GM, J Inherit Metab Dis 2011 34 991 1001 10.1007/s10545-011-9368-7 21779792
80. Dietary modifications in patients receiving miglustat. Champion H, Ramaswami U, Imrie J, Lachmann RH, Gallagher J, Cox TM, Wraith JE, J Inherit Metab Dis 2010 [Epub ahead of print] doi: 10.1007/s10545-008-0923-9
81. Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy. Chio A, Calvo A, Ghiglione P, Mazzini L, Mutani R, Mora G, J Neurol Neurosurg Psychiatry 2010 81 1141 1143 10.1136/jnnp.2009.175984 20660920
82. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, Vandenberghe N, Desnuelle C, Guy N, Camdessanche JP, Cintas P, et al. Eur J Neurol 2008 15 1245 1251 10.1111/j.1468-1331.2008.02307.x 18973614
83. Mushroom-cage gastrostomy tube placement in patients with amyotrophic lateral sclerosis: a 5-year experience in 104 patients in a single institution. Lewis D, Ampong MA, Rio A, Willey E, Johnson J, Shaw CE, Ellis CM, Al-Chalabi A, Leigh PN, Sidhu PS, Eur Radiol 2009 19 1763 1771 10.1007/s00330-009-1307-8 19190913
84. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation. Lo Coco D, Marchese S, La Bella V, Piccoli T, Lo Coco A, Chest 2007 132 64 69 10.1378/chest.06-2712 17475635 (Pubitemid 47068204)
85. Late onset Huntington Disease: clinical and genetic characteristics of 34 cases. Lipe H, Bird T, J Neurol Sci 2009 276 159 162 10.1016/j.jns.2008.09.029 18977004
86. The natural history of multiple sclerosis. Deshpande R, Kremenchutzky M, Rice GP, Adv Neurol 2006 98 1 15 16400823
87. Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study. Ebers GC, Reder AT, Traboulsee A, Li D, Langdon D, Goodin DS, Wolf C, Beckmann K, Konieczny A, Clin Ther 2009 31 1724 1736 10.1016/j.clinthera.2009.08.003 19808131
88. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, Ouyang J, Kozak T, Moore J, Kotter I, et al. Haematologica 2010 95 284 292 10.3324/haematol.2009.013458 19773265
89. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients. Smestad C, Sandvik L, Celius EG, Mult Scler 2009 15 1263 1270 10.1177/1352458509107010 19812114
90. Causes of death among patients with multiple sclerosis. Sumelahti ML, Hakama M, Elovaara I, Pukkala E, Mult Scler 2010 16 1437 1442 10.1177/1352458510379244 20826526
91. The cause of death in idiopathic Parkinson's disease. Pennington S, Snell K, Lee M, Walker R, Parkinsonism Relat Disord 2010 16 434 437 10.1016/j.parkreldis.2010.04.010 20570207
92. Long-term survival of Parkinson's disease: a population-based study. D'Amelio M, Ragonese P, Morgante L, Reggio A, Callari G, Salemi G, Savettieri G, J Neurol 2006 253 33 37 10.1007/s00415-005-0916-7 16021349 (Pubitemid 43157385)
93. Epidemiology of Parkinson disease in the city of Kolkata, India: a community-based study. Das SK, Misra AK, Ray BK, Hazra A, Ghosal MK, Chaudhuri A, Roy T, Banerjee TK, Raut DK, Neurology 2010 75 1362 1369 10.1212/WNL. 0b013e3181f735a7 20938028
94. Mortality in Parkinson's disease, a 20-year follow-up study. Diem-Zangerl A, Seppi K, Oberaigner W, Poewe W, Mov Disord 2010 25 661 662 10.1002/mds.22934 20201025
95. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G, Neurology 2008 70 1423 1430 10.1212/01.wnl.0000310414.85144.ee 18413567 (Pubitemid 351521935)
96. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up. Fall PA, Saleh A, Fredrickson M, Olsson JE, Granerus AK, Mov Disord 2003 18 1312 1316 10.1002/mds.10537 14639673 (Pubitemid 38263316)
97. Physical assessment as a predictor of mortality in people with Parkinson's disease: a study over 7 years. Gray WK, Hildreth A, Bilclough JA, Wood BH, Baker K, Walker RW, Mov Disord 2009 24 1934 1940 10.1002/mds.22610 19672988
98. Survival and cause of death in multiple sclerosis: Results from a 50-year follow-up in Western Norway. Grytten TN, Lie SA, Aarseth JH, Mult Scler 2008 14 1191 1198 10.1177/1352458508093890 18632781
99. Survival and cause of death in multiple sclerosis: a prospective population-based study. Hirst C, Swingler R, Compston DA, Ben-Shlomo Y, Robertson NP, J Neurol Neurosurg Psychiatry 2008 79 1016 1021 10.1136/jnnp.2007.127332 18303108
100. Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus. Schupbach MW, Welter ML, Bonnet AM, Elbaz A, Grossardt BR, Mesnage V, Houeto JL, Maltete D, Mallet L, Rocca WA, et al. Mov Disord 2007 22 257 261 10.1002/mds.21264 17149702 (Pubitemid 46374774)
101. Surgical, medical, and hardware adverse events in a series of 141 patients undergoing subthalamic deep brain stimulation for Parkinson disease. Vergani F, Landi A, Pirillo D, Cilia R, Antonini A, Sganzerla EP, World Neurosurg 2010 73 338 344 10.1016/j.wneu.2010.01.017 20849789
102. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ, Parkinsonism Relat Disord 2008 14 114 119 10.1016/j.parkreldis. 2007.06.012 17822940 (Pubitemid 351735982)
103. Sensory testing in the assessment of laryngeal sensation in patients with amyotrophic lateral sclerosis. Amin MR, Harris D, Cassel SG, Grimes E, Heiman-Patterson T, Ann Otol Rhinol Laryngol 2006 115 528 534 16900807 (Pubitemid 44066191)
104. Assessment of swallowing by oropharyngoesophageal scintigraphy in patients with amyotrophic lateral sclerosis. Fattori B, Grosso M, Bongioanni P, Nacci A, Cristofani R, AlSharif A, Licitra R, Matteucci F, Rossi B, Rubello D, et al. Dysphagia 2006 21 280 286 17221290 (Pubitemid 46160660)
105. Survival and prognostic factors of motor neuron disease in a multi-ethnic Asian population. Goh KJ, Tian S, Shahrizaila N, Ng CW, Tan CT, Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2011 12 124 129
106. Diet at time of procedure predicts complications after percutaneous endoscopic gastrostomy placement in ALS. Larson S, Tiryaki E, Amyotroph Lateral Scler 2009 10 Suppl 1 53 54 18985466
107. Oral Secretions Scale-Test-Re-Test Reliability pilot study in a Japanese amyotrophic lateral sclerosis population. Nakayama Y, Ogura A, Matsuda C, Amyotroph Lateral Scler 2010 11 Suppl 1 141
108. Prolonged apnea/hypopnea during water swallowing in patients with amyotrophic lateral sclerosis. Nozaki S, Sugishita S, Saito T, Umaki Y, Adachi K, Shinno S, Rinsho shinkeigaku = Clinical neurology 2008 48 634 639 10.5692/clinicalneurol.48.634 19048945
109. Influence of physical activity in the evolution of ALS. de Rivera Rodriguez FJ, Sanz G, Oreja GC, Amyotroph Lateral Scler 2010 11 1 123
110. [Analysis of oropharyngeal phase of swallowing in patients with amyotrophic lateral sclerosis]. Tomik J, Tomik B, Skladzien J, Gajec S, Strek P, Oles K, Gawlik J, Wiatr M, Przegl Lek 2009 66 905 908 20297626
111. A clinical epidemiological study of 251 cases of amyotrophic lateral sclerosis in the south of Brazil. Werneck LC, Bezerra R, Silveira Neto O, Scola RH, Arq Neuropsiquiatr 2007 65 189 195 10.1590/S0004-282X2007000200001 17607412 (Pubitemid 47015930)
112. Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease. Aziz NA, Anguelova GV, Marinus J, van Dijk JG, Roos RA, Eur J Neurol 2010 17 1068 1074 10.1111/j.1468-1331.2010.02973.x 20192977
113. Clinical features of Huntington disease in 243 Chinese patients. Guo X, Zhang S, Burgunder J-M, Neural Regeneration Research 2010 5 102 107
114. Clinical features of Huntington's disease in 241 Chinese patients. Guo X-Y, Zhang S-S, Zhao B, Mov Disord 2010 25 Suppl 2 276
115. The DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis. Bergamaschi R, Crivelli P, Rezzani C, Patti F, Solaro C, Rossi P, Restivo D, Maimone D, Romani A, Bastianello S, et al. J Neurol Sci 2008 269 49 53 10.1016/j.jns.2007.12.021 18280504
116. Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis. Bergamaschi R, Rezzani C, Minguzzi S, Amato MP, Patti F, Marrosu MG, Bonavita S, Grasso MG, Ghezzi A, Rottoli M, et al. Funct Neurol 2009 24 159 162 20018144
117. Oropharyngeal dysphagia in multiple sclerosis. Poorjavad M, Derakhshandeh F, Etemadifar M, Soleymani B, Minagar A, Maghzi AH, Mult Scler 2010 16 362 365 10.1177/1352458509358089 20203150
118. Prevalence of dysphagia [sic] in multiple sclerosis: An Italian multicentre study. Solaro C, Rezani C, Bergamaschi R, Mult Scler 2009 15 259 S260
119. A health profile of adults with multiple sclerosis living in the community. Vazirinejad R, Lilley J, Ward C, Mult Scler 2008 14 1099 1105 10.1177/1352458508092264 18653738
120. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Chinnery PF, Crompton DE, Birchall D, Jackson MJ, Coulthard A, Lombes A, Quinn N, Wills A, Fletcher N, Mottershead JP, et al. Brain 2007 130 110 119 17142829 (Pubitemid 46026227)
121. Lung function and disability in neuromuscular patients at first admission to a respiratory clinic. Fiorenza D, Vitacca M, Bianchi L, Gabbrielli L, Ambrosino N, Respir Med 2011 105 151 158 10.1016/j.rmed.2010.09.018 20965709
122. Frequency and treatment of depressive symptoms in a Parkinson's disease registry. Althaus A, Becker OA, Spottke A, Dengler R, Schneider F, Kloss M, Eggert K, Oertel WH, Dillmann U, Herting B, et al. Parkinsonism Relat Disord 2008 14 626 632 10.1016/j.parkreldis.2008.01.016 18406197
123. Manometry and impedance characteristics of the esophagus in patients with early stage of idiopathic Parkinson's disease. Choi M-G, Park JM, Cho YK, Gastroenterology 2009 136 92 A93
124. Late-stage Parkinson's disease: the Barcelona and Lisbon cohort. Coelho M, Marti MJ, Tolosa E, Ferreira JJ, Valldeoriola F, Rosa M, Sampaio C, J Neurol 2010 257 1524 1532 10.1007/s00415-010-5566-8 20411272
125. A therapeutic maneuver for oropharyngeal dysphagia in patients with Parkinson's disease. Felix VN, Correa SM, Soares RJ, Clinics (Sao Paulo) 2008 63 661 666 10.1590/S1807-59322008000500015
126. Dysphagia in Parkinson's disease improves by subthalamic high frequency stimulation. Galazky I, Vorwerk W, Voges J, Mov Disord 2010 25 Suppl 2 443
127. The coordination of breathing and swallowing in Parkinson's disease. Gross RD, Atwood CW Jr, Ross SB, Eichhorn KA, Olszewski JW, Doyle PJ, Dysphagia 2008 23 136 145 10.1007/s00455-007-9113-4 18027027
128. Prevalence and definition of drooling in Parkinson's disease: a systematic review. Kalf JG, de Swart BJ, Borm GF, Bloem BR, Munneke M, J Neurol 2009 256 1391 1396 10.1007/s00415-009-5098-2 19288042
129. Use of thickened liquids versus postural change as an immediate intervention for thin-liquid aspiration in individuals with neurogenic dysphagia: No easy answers. Kelchner LN, Evidence-Based Communication Assessment and Intervention 2009 3 19 23 10.1080/17489530902781558
130. Simple clinical tests may predict severe oropharyngeal dysphagia in Parkinson's disease. Lam K, Lam FK, Lau KK, Chan YK, Kan EY, Woo J, Wong FK, Ko A, Mov Disord 2007 22 640 644 10.1002/mds.21362 17266075 (Pubitemid 46800132)
131. Clinical features in early Parkinson disease and survival. Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, McGuire V, Quesenberry CP, Nelson LM, Van Den Eeden SK, Arch Neurol 2009 66 1353 1358 10.1001/archneurol. 2009.221 19901166
132. Anxiety, depression and swallowing disorders in patients with Parkinson's disease. Manor Y, Balas M, Giladi N, Mootanah R, Cohen JT, Parkinsonism Relat Disord 2009 15 453 456 10.1016/j.parkreldis.2008.11.005 19071054
133. Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease. Manor Y, Giladi N, Cohen A, Fliss DM, Cohen JT, Mov Disord 2007 22 1917 1921 10.1002/mds.21625 17588237 (Pubitemid 350134205)
134. Swallowing problems in Parkinson disease: frequency and clinical correlates. Miller N, Allcock L, Hildreth AJ, Jones D, Noble E, Burn DJ, J Neurol Neurosurg Psychiatry 2009 80 1047 1049 10.1136/jnnp.2008.157701 19028764
135. Dysphagia and sialorrhea associated with Parkinson's disease. Nicaretta DH, Rosso ALZ, De Mattos JP, Mov Disord 2010 25 Suppl 2 333
136. Silent aspiration in Parkinson's disease patients with diurnal sialorrhea. Nobrega AC, Rodrigues B, Melo A, Clin Neurol Neurosurg 2008 110 117 119 10.1016/j.clineuro.2007.09.011 18023964
137. Does botulinum toxin injection in parotid glands interfere with the swallowing dynamics of Parkinson's disease patients? Nobrega AC, Rodrigues B, Melo A, Clin Neurol Neurosurg 2009 111 430 432 10.1016/j.clineuro.2008.12.007 19181440
138. Is drooling secondary to a swallowing disorder in patients with Parkinson's disease? Nobrega AC, Rodrigues B, Torres AC, Scarpel RD, Neves CA, Melo A, Parkinsonism Relat Disord 2008 14 243 245 10.1016/j.parkreldis.2007.08. 003 17892967 (Pubitemid 351458424)
139. Dysphagia and hypersalivation in Parkinson's disease: A cross-sectional survey. Perez-Lloret S, Negre-Pages L, Merello M, Eur J Neurol 2009 16 608 10.1111/j.1468-1331.2009.02554.x 19222548
140. Clinical manifestation of patients with Parkinson's disease carriers of
141. Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy. Warnecke T, Oelenberg S, Teismann I, Hamacher C, Lohmann H, Ringelstein EB, Dziewas R, Mov Disord 2010 25 1239 1245 10.1002/mds.23060 20629130
142. A retrospective study about characteristics of Wilson's disease at tertiary care institute of North India. Kumar A, Kumar R, Kumar U, Mov Disord 2010 25 Suppl 2 260